Login to Your Account

FDA approves Astrazeneca gout drug Zurampic

By Michael Fitzhugh
Staff Writer

Wednesday, December 23, 2015

A week earlier than expected, Astrazeneca plc has gained FDA approval to market Zurampic (lesinurad), a new drug for treating high levels of uric acid in the blood associated with gout when given together with xanthine oxidase inhibitors (XOIs). It's the 45th new molecular entity approved by the agency this year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription